Oncological Studies

Cancer affects us all, whether we have it, care about someone who does, or worry about getting it in future. Oncology is one of the most challenging fields in clinical research. During recent years, few effective treatments have been developed and licensed to treat certain cancers. Some companies do have very promising drugs in the pipeline. However, the mortality rate of cancer is far too high and much more clinical research is needed to decrease this rate significantly. Oncological studies have to adhere to special rules, which are usually longer and more complex than those targeting other diseases. Due to the complexity and variability of the different oncological indications, GCP-Service has extensive experience with a range of oncological studies. We have performed phase I, II, III and non-intervention clinical studies for the following indications:

  • Bladder cancer
  • Breast cancer
  • Cervix cancer
  • Colon cancer
  • Gastric cancer
  • Head cancer
  • Leukaemia
  • Lung cancer
  • Malignant lymphoma
  • Neck cancer
  • Pancreatic cancer

Since the beginning of 2009, GCP-Service also offers oncology SMO (Study Management Organisation) services. The combination of medical and scientific competence of GCP-Service Oncology optimises the return on your clinical research investments. We treat nearly all oncological indications on an outpatient basis. With a huge geographical service area throughout northern Germany, GCP-Service can achieve your recruitment goals and provide you with high quality and reliable data.